Hong Kong Innovative Drug Stocks Rally; Everest Medicines Jumps Nearly 80%
Hong Kong-listed innovative drug concept stocks moved higher collectively during trading on August 20, 2026. Everest Medicines saw its share price surge sharply in early trading, with gains approaching 80%. GenScript Biotech rose more than 15%, CSPC Pharmaceutical gained over 13%, and XtalPi Holdings advanced nearly 10%. The notable performance of these stocks on the day drove the overall activity of the related sector.